Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer

Author(s): Peyman Ranji, Zahra Heydari, Ali Mohammad Alizadeh.

Journal Name: Current Cancer Drug Targets

Volume 15 , Issue 7 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Drug resistance primarily appears where there is altered drug metabolism or target modification. It is a major challenge in cancer therapy which affects treatment process, and limits chemotherapeutics. Recently, nanotechnological approaches were shown to be capable of lowering drug side effects and protecting from enzymatic degradation. Therefore, patient’s compliance and survival rate have dramatically increased. This review elaborates on the structures and functions of the factors involved in cancer drug resistance together with nanobiotechnological approaches for overcoming the obstacles in breast cancer research and therapy. The present paper provides information and suggestions to both basic and clinical researchers to develop new nanobiotechnological methods to improve breast cancer modalities especially in drug resistance.

Keywords: Breast cancer, drug resistance, nanotechnology, review.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [544 - 562]
Pages: 19
DOI: 10.2174/1568009615666150706102842
Price: $65

Article Metrics

PDF: 36